The target sign, identified at chest computed tomography, has been recently described by Müller et al ([@r1]) as a nodular opacity in the center of a ring-like opacity in patients with pneumonia caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Pulmonary vascular alterations are significantly associated with the new coronavirus disease (COVID-19) ([@r2],[@r3]), and lung autopsies showed distinctive vascular features characterized by endothelial injury with disrupted cell membranes (endothelialitis), widespread thrombosis with microangiopathy, and angiocentric inflammation ([@r4]). Thus, the central nodular opacity may reflect the perivascular inflammation or focal enlargement of the pulmonary artery ([@r1]). Furthermore, the ring-like opacities may be correlated with the underlying pathophysiology of the disease process as it organizes, indicating that the organizing pneumonia is one of the mechanisms of lung injury, but distinct from the reversed halo sign and the perilobular opacity ([@r1]). The variant of target sign described here is characterized by multiple concentric perivascular ring-like opacities. Further evaluation and pathologic studies are required to investigate the contribution of this sign in the diagnosis of COVID-19 pneumonia.

![Schematic drawing (A, E) and chest computed tomography images (B -- axial, C -- coronal, D -- sagittal and E -- sagittal oblique) show the target sign characterized by nodular opacity in the center of a ring-like opacity. Some MPR planes (E) show the central nodule as a pulmonary arteriole (arrowhead) with perivascular ground-glass tubular opacity, as illustrated in F.](ryct.2020200435.fig1){#fig1}

![Schematic drawing (A) and chest computed tomography images (B to D -- axial oblique, E -- coronal and F -- sagittal) show the variant target sign characterized by multiple concentric ring-like opacities with a central nodular peribroncovascular opacity.](ryct.2020200435.fig2){#fig2}
